Vibramycin en es it fr

Vibramycin Brand names, Vibramycin Analogs

Vibramycin Brand Names Mixture

  • No information avaliable

Vibramycin Chemical_Formula

C22H24N2O8

Vibramycin RX_link

http://www.rxlist.com/cgi/generic/doxycyc.htm

Vibramycin fda sheet

Vibramycin FDA

Vibramycin msds (material safety sheet)

Vibramycin MSDS

Vibramycin Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Vibramycin Molecular Weight

444.435 g/mol

Vibramycin Melting Point

201 oC

Vibramycin H2O Solubility

630 mg/L

Vibramycin State

Solid

Vibramycin LogP

-1.219

Vibramycin Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Vibramycin Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Vibramycin Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Vibramycin Absorption

completely absorbed after oral administration

Vibramycin side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Vibramycin Patient Information

Vibramycin Organisms Affected

Enteric bacteria and other eubacteria